
Xiangxue
300147.SZXiangxue Pharmaceutical Co.,Ltd. Price (300147.SZ)
Stock Price
Market Cap
Fetching Data...
Enterprise Value
Fetching Data...
Volume
Fetching Data...
Shares Outstanding
659,260,750
(0.0823)%Income Statement Summary
Revenue | |
Cost of Revenue | |
Gross Profit | |
Operating Expenses | |
Operating Income | |
Other Expenses | |
Net Income |


Income Statement
Xiangxue Pharmaceutical Co.,Ltd.Currency: CNY
YEAR | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | |||||||||||||||||||
Revenue |
258,307,517.00
+0% |
294,808,980.00
+14% |
378,633,317.00
+28% |
513,383,583.00
+36% |
616,090,220.00
+20% |
801,020,212.00
+30% |
1,261,114,651.00
+57% |
1,523,980,138.00
+21% |
1,464,604,842.00
-4% |
1,862,087,873.00
+27% |
2,187,317,438.00
+17% |
2,504,252,347.00
+14% |
2,786,199,516.00
+11% |
3,072,090,655.00
+10% |
2,970,575,841.00
-3% |
2,187,069,901.00
-26% |
2,299,287,682.00
+5% |
||
Cost of Revenue | |||||||||||||||||||
Cost of Revenue | 136,594,164.00 | 141,746,117.00 | 184,401,806.00 | 271,367,783.00 | 327,169,266.00 | 417,531,306.00 | 742,583,995.00 | 888,856,243.00 | 839,083,217.00 | 1,274,021,016.00 | 1,542,067,158.00 | 1,591,112,241.00 | 1,905,396,940.00 | 2,079,524,432.00 | 2,191,294,685.00 | 1,644,557,065.00 | 1,509,521,251.00 | ||
Gross Profit | |||||||||||||||||||
Gross Profit |
121,713,353.00
+0% |
153,062,863.00
+26% |
194,231,511.00
+27% |
242,015,800.00
+25% |
288,920,954.00
+19% |
383,488,906.00
+33% |
518,530,656.00
+35% |
635,123,895.00
+22% |
625,521,625.00
-2% |
588,066,857.00
-6% |
645,250,280.00
+10% |
913,140,106.00
+42% |
880,802,576.00
-4% |
992,566,223.00
+13% |
779,281,156.00
-21% |
542,512,836.00
-30% |
789,766,431.00
+46% |
||
Gross Profit Ratio | (0.47%) | (0.52%) | (0.51%) | (0.47%) | (0.47%) | (0.48%) | (0.41%) | (0.42%) | (0.43%) | (0.32%) | (0.29%) | (0.36%) | (0.32%) | (0.32%) | (0.26%) | (0.25%) | (0.34%) | ||
Operating Expenses | |||||||||||||||||||
Research and Development | 0.00 | 0.00 | 0.00 | 15,508,685.00 | 19,708,960.00 | 25,655,293.00 | 31,603,121.00 | 50,761,700.00 | 45,603,101.00 | 33,287,563.00 | 40,047,560.00 | 38,670,789.00 | 61,268,399.00 | 66,989,910.00 | 90,603,637.00 | 94,792,768.00 | 102,811,459.00 | ||
General and Administrative | 25,996,245.00 | 29,197,803.00 | 39,521,265.00 | 13,437,765.00 | 16,513,633.00 | 22,439,577.00 | 28,524,013.00 | 32,795,110.00 | 31,034,327.00 | 44,616,924.00 | 53,115,586.00 | 66,488,256.00 | 63,575,986.00 | 91,355,028.00 | 105,963,801.00 | 88,103,680.00 | 64,572,137.00 | ||
Selling, General & Admin... | 80,673,111.00 | 104,027,758.00 | 117,831,404.00 | 96,202,991.00 | 126,011,597.00 | 154,160,781.00 | 187,186,998.00 | 235,743,906.00 | 248,369,118.00 | 295,688,717.00 | 361,229,807.00 | 439,793,841.00 | 458,896,614.00 | 430,393,455.00 | 487,580,554.00 | 421,244,939.00 | 287,932,116.00 | ||
Selling & Marketing Exp... | 54,676,866.00 | 74,829,955.00 | 78,310,139.00 | 82,765,226.00 | 109,497,963.00 | 131,721,204.00 | 158,662,984.00 | 202,948,795.00 | 217,334,790.00 | 251,071,793.00 | 308,114,221.00 | 373,305,585.00 | 395,320,628.00 | 339,038,427.00 | 381,616,752.00 | 333,141,258.00 | 223,359,978.00 | ||
Depreciation and Amortiz... | 15,191,690.00 | 15,196,970.00 | 14,111,138.00 | 18,409,742.00 | 24,505,515.00 | 33,776,557.00 | 42,145,836.00 | 69,242,909.00 | 83,400,150.00 | 105,516,256.00 | 112,473,127.00 | 105,516,256.00 | 121,809,926.00 | 149,836,145.00 | 164,892,321.00 | 247,083,603.00 | 237,297,905.00 | ||
Other Expenses | -763,918.34 | 166,636,003.00 | 588,665.00 | 1,207,769.00 | 3,552,269.00 | 3,811,143.00 | 17,321,600.00 | 17,678,451.00 | 31,953,605.00 | 55,820,664.00 | 20,349,159.00 | -14,022,312.96 | 144,173,206.00 | 130,891,294.00 | 156,002,554.00 | 172,820,169.00 | 744,794,497.00 | ||
Total Operating Expenses | 82,823,192.00 | 106,307,652.00 | 121,054,323.00 | 138,956,308.00 | 185,594,812.00 | 235,299,282.00 | 284,086,343.00 | 375,630,373.00 | 390,372,815.00 | 454,052,971.00 | 490,951,951.00 | 619,512,999.00 | 664,338,220.00 | 628,274,660.00 | 734,186,746.00 | 688,857,877.00 | 1,122,482,570.00 | ||
Cost and Exponses | 219,417,356.00 | 248,053,769.00 | 305,456,130.00 | 410,324,092.00 | 512,764,079.00 | 652,830,589.00 | 1,026,670,339.00 | 1,264,486,617.00 | 1,229,456,033.00 | 1,728,073,988.00 | 2,033,019,109.00 | 2,210,625,241.00 | 2,569,735,160.00 | 2,707,799,092.00 | 2,925,481,432.00 | 2,333,414,942.00 | 2,632,003,821.00 | ||
Operating Income | |||||||||||||||||||
Operating Income |
35,778,468.00
+0% |
35,320,634.00
-1% |
60,107,343.00
+70% |
86,843,630.00
+44% |
97,193,983.00
+12% |
125,688,136.00
+29% |
177,334,133.00
+41% |
206,941,773.00
+17% |
185,564,618.00
-10% |
59,209,876.00
-68% |
105,549,659.00
+78% |
126,025,614.00
+19% |
275,211,774.00
+118% |
327,972,748.00
+19% |
34,986,071.00
-89% |
-152,934,823.45
-537% |
53,791,913.00
-135% |
||
Operating Income Ratio | (0.14%) | (0.12%) | (0.16%) | (0.17%) | (0.16%) | (0.16%) | (0.14%) | (0.14%) | (0.13%) | (0.03%) | (0.05%) | (0.05%) | (0.10%) | (0.11%) | (0.01%) | (-0.07%) | (0.02%) | ||
Other Income and Exp... | |||||||||||||||||||
Interest Income | 202,494.00 | 99,838.00 | 97,930.00 | 1,251,111.00 | 13,640,577.00 | 17,673,234.00 | 18,480,139.00 | 20,478,296.00 | 19,748,288.00 | 8,946,522.00 | 3,755,253.00 | 6,256,111.00 | 4,172,772.00 | 5,095,090.00 | 8,250,698.00 | 3,913,373.00 | 1,204,192.00 | ||
Interest Expenses | 1,776,281.00 | 6,150,519.00 | 11,302,397.00 | 15,750,477.00 | 18,618,040.00 | 38,977,297.00 | 70,551,772.00 | 70,584,221.00 | 50,495,330.00 | 68,163,737.00 | 150,925,760.00 | 145,681,558.00 | 150,680,013.00 | 130,290,579.00 | 202,055,351.00 | 213,201,429.00 | 237,058,755.00 | ||
Total Other Income/Exp... | -763,918.00 | 5,356,482.00 | -10,694,201.00 | -13,291,832.00 | 3,552,270.00 | -17,672,043.00 | -35,627,685.00 | -33,163,110.00 | 31,937,402.00 | 54,649,095.00 | 20,349,159.00 | -140,986,632.00 | -158,134,961.00 | -145,707,257.00 | -657,329,861.45 | -337,417,453.00 | -442,742,785.00 | ||
EBITDA | |||||||||||||||||||
EBITDA | 51,982,521.00 | 62,222,130.00 | 86,188,572.00 | 122,214,229.00 | 143,869,804.00 | 202,253,247.00 | 308,049,625.00 | 365,011,511.00 | 357,680,662.00 | 289,994,800.00 | 405,330,171.00 | 370,333,482.00 | 412,428,045.00 | 319,628,115.00 | -238,119,122.00 | 89,361,902.00 | 151,218,966.00 | ||
EBITDA ratio | (0.21%) | (0.77%) | (0.23%) | (0.24%) | (0.24%) | (0.25%) | (0.25%) | (0.24%) | (0.26%) | (0.16%) | (0.19%) | (0.18%) | (0.14%) | (0.15%) | (0.06%) | (0.04%) | (0.07%) | ||
Income Before Tax | |||||||||||||||||||
Income Before Tax | 35,014,550.00 | 40,677,116.00 | 60,696,009.00 | 88,051,399.00 | 100,746,253.00 | 129,499,280.00 | 194,655,734.00 | 224,595,044.00 | 217,502,020.00 | 114,599,294.00 | 125,898,818.00 | 112,003,301.00 | 117,076,813.00 | 166,138,582.00 | -635,775,090.23 | -514,716,214.46 | -388,950,872.00 | ||
Income Before Tax Ratio | (0.14%) | (0.14%) | (0.16%) | (0.17%) | (0.16%) | (0.16%) | (0.15%) | (0.15%) | (0.15%) | (0.06%) | (0.06%) | (0.04%) | (0.04%) | (0.05%) | (-0.21%) | (-0.24%) | (-0.17%) | ||
Income Tax Expense | |||||||||||||||||||
Income Tax Expense | 3,319,727.00 | 3,399,406.00 | 8,640,754.00 | 12,636,070.00 | 15,866,962.00 | 20,325,626.00 | 23,564,341.00 | 8,051,132.00 | 15,855,754.00 | 16,962,334.00 | 13,773,799.00 | 24,032,540.00 | -9,052,752.38 | 24,341,266.00 | 22,922,192.00 | -6,795,018.33 | 12,795,348.00 | ||
Net Income | |||||||||||||||||||
Net Income | 30,780,829.00
+0% |
35,950,730.00
+17% |
50,916,528.00
+42% |
74,199,468.00
+46% |
83,496,930.00
+13% |
107,167,519.00
+28% |
158,242,572.00
+48% |
196,796,127.00
+24% |
177,297,884.00
-10% |
66,024,144.00
-63% |
65,939,178.00
0% |
56,439,310.00
-14% |
126,129,566.00
+123% |
141,797,316.00
+12% |
-658,697,282.65
-565% |
-507,921,196.13
-23% |
-388,963,842.00
-23% |
||
Net Income Ratio | (0.12%) | (0.12%) | (0.13%) | (0.14%) | (0.14%) | (0.13%) | (0.13%) | (0.13%) | (0.12%) | (0.04%) | (0.03%) | (0.02%) | (0.05%) | (0.05%) | (-0.22%) | (-0.23%) | (-0.17%) | ||
Earning Per Share | |||||||||||||||||||
Basic EPS | 0.08 | 0.09 | 0.13 | 0.16 | 0.14 | 0.18 | 0.33 | 0.32 | 0.28 | 0.10 | 0.10 | 0.09 | 0.19 | 0.22 | -1.00 | -0.77 | -0.59 | ||
Diluted EPS | 0.08 | 0.09 | 0.13 | 0.16 | 0.14 | 0.18 | 0.33 | 0.32 | 0.28 | 0.10 | 0.10 | 0.09 | 0.19 | 0.22 | -1.00 | -0.77 | -0.59 | ||
Share Outstanding | |||||||||||||||||||
Basic Share Outstanding | 396,511,251.00 | 399,957,497.00 | 396,376,703.00 | 454,014,377.00 | 608,219,070.00 | 600,494,937.00 | 477,445,931.00 | 614,987,898.00 | 633,206,731.00 | 660,241,450.00 | 659,391,780.00 | 627,103,454.00 | 652,708,731.00 | 655,304,542.00 | 658,718,543.00 | 658,718,543.00 | 659,260,750.00 | ||
Diluted Share Outstanding | 396,511,251.00 | 399,957,497.00 | 396,376,703.00 | 454,014,377.00 | 608,219,070.00 | 600,494,937.00 | 477,445,931.00 | 614,987,898.00 | 633,206,731.00 | 660,241,450.00 | 659,391,780.00 | 627,103,454.00 | 652,708,731.00 | 655,304,542.00 | 658,718,543.00 | 658,718,543.00 | 659,260,750.00 |